194 related articles for article (PubMed ID: 37236420)
1. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies.
Putera I; Schrijver B; Ten Berge JCEM; Gupta V; La Distia Nora R; Agrawal R; van Hagen PM; Rombach SM; Dik WA
Prog Retin Eye Res; 2023 Jul; 95():101189. PubMed ID: 37236420
[TBL] [Abstract][Full Text] [Related]
2. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R; Testi I; Bodaghi B; Barisani-Asenbauer T; McCluskey P; Agarwal A; Kempen JH; Gupta A; Smith JR; de Smet MD; Yuen YS; Mahajan S; Kon OM; Nguyen QD; Pavesio C; Gupta V;
Ophthalmology; 2021 Feb; 128(2):277-287. PubMed ID: 32603726
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
Agrawal R; Gunasekeran DV; Grant R; Agarwal A; Kon OM; Nguyen QD; Pavesio C; Gupta V;
JAMA Ophthalmol; 2017 Dec; 135(12):1318-1327. PubMed ID: 29075752
[TBL] [Abstract][Full Text] [Related]
4. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.
Ang M; Hedayatfar A; Wong W; Chee SP
Br J Ophthalmol; 2012 Mar; 96(3):332-6. PubMed ID: 21719564
[TBL] [Abstract][Full Text] [Related]
5. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.
Agarwal A; Agrawal R; Gunasekaran DV; Raje D; Gupta B; Aggarwal K; Murthy SL; Westcott M; Chee SP; McCluskey P; Ling HS; Teoh S; Cimino L; Biswas J; Narain S; Agarwal M; Mahendradas P; Khairallah M; Jones N; Tugal-Tutkun I; Babu K; Basu S; Carreño E; Lee R; Al-Dhibi H; Bodaghi B; Invernizzi A; Goldstein DA; Herbort CP; Barisani-Asenbauer T; González-López JJ; Androudi S; Bansal R; Moharana B; Mahajan S; Esposti S; Tasiopoulou A; Nadarajah S; Agarwal M; Abraham S; Vala R; Singh R; Sharma A; Sharma K; Zierhut M; Kon OM; Cunningham E; Nguyen QD; Pavesio C; Gupta V
Ocul Immunol Inflamm; 2019; 27(3):465-473. PubMed ID: 29261089
[No Abstract] [Full Text] [Related]
6. Pathogenesis of ocular tuberculosis: New observations and future directions.
Basu S; Elkington P; Rao NA
Tuberculosis (Edinb); 2020 Sep; 124():101961. PubMed ID: 33010848
[TBL] [Abstract][Full Text] [Related]
7. Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis.
Alli HD; Ally N; Mayet I; Dangor Z; Madhi SA
Surv Ophthalmol; 2022; 67(3):770-792. PubMed ID: 34626620
[TBL] [Abstract][Full Text] [Related]
8. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis.
Agrawal R; Testi I; Mahajan S; Yuen YS; Agarwal A; Kon OM; Barisani-Asenbauer T; Kempen JH; Gupta A; Jabs DA; Smith JR; Nguyen QD; Pavesio C; Gupta V;
Ophthalmology; 2021 Feb; 128(2):266-276. PubMed ID: 32115264
[TBL] [Abstract][Full Text] [Related]
9. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.
Sudharshan S; Ganesh SK; Balu G; Mahalakshmi B; Therese LK; Madhavan HN; Biswas J
Int Ophthalmol; 2012 Jun; 32(3):217-23. PubMed ID: 22527447
[TBL] [Abstract][Full Text] [Related]
10. Clinical Course and Outcomes of Pediatric Tubercular Uveitis in North India.
Kaur S; Aggarwal K; Agarwal A; Suri D; Gupta A; Singh R; Bansal R; Singh S; Singh N; Gupta A; Gupta V
Ocul Immunol Inflamm; 2018; 26(6):859-864. PubMed ID: 28318350
[TBL] [Abstract][Full Text] [Related]
11. Polymerase Chain Reaction and its Correlation with Clinical Features and Treatment Response in Tubercular Uveitis.
Sudheer B; Lalitha P; Kumar AL; Rathinam S
Ocul Immunol Inflamm; 2018; 26(6):845-852. PubMed ID: 28665743
[TBL] [Abstract][Full Text] [Related]
12. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists.
Lou SM; Larkin KL; Winthrop K; Rosenbaum JT;
Ocul Immunol Inflamm; 2015 Feb; 23(1):25-31. PubMed ID: 25019973
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous mutually exclusive active tubercular posterior uveitis.
Ramanjulu R; Dubey D; Shanmugam MP
Indian J Ophthalmol; 2020 Sep; 68(9):2049-2050. PubMed ID: 32823477
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment.
Danjou W; Pradat P; Jamilloux Y; Gerfaud-Valentin M; Kodjikian L; Trad S; Seve P
Br J Ophthalmol; 2023 Apr; 107(4):500-504. PubMed ID: 34711577
[TBL] [Abstract][Full Text] [Related]
15. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis.
Agrawal R; Gupta B; Gonzalez-Lopez JJ; Rahman F; Phatak S; Triantafyllopoulou I; Addison PK; Westcott M; Pavesio CE
Ocul Immunol Inflamm; 2015 Feb; 23(1):40-6. PubMed ID: 25615809
[TBL] [Abstract][Full Text] [Related]
16. Tuberculous Uveitis Presenting with a Bullous Exudative Retinal Detachment: A Case Report and Systematic Literature Review.
Song JH; Koreishi AF; Goldstein DA
Ocul Immunol Inflamm; 2019; 27(6):998-1009. PubMed ID: 29969330
[No Abstract] [Full Text] [Related]
17. Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Tomkins-Netzer O; Leong BCS; Zhang X; Lightman S; McCluskey PJ;
Am J Ophthalmol; 2018 Jun; 190():164-170. PubMed ID: 29604284
[TBL] [Abstract][Full Text] [Related]
18. Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting.
Basu S; Nayak S; Padhi TR; Das T
Eye (Lond); 2013 May; 27(5):657-62. PubMed ID: 23449506
[TBL] [Abstract][Full Text] [Related]
19. The blinding bug found in the eye.
Agarwal M; Paul L; Gupta C; Rani PK
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642860
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region.
Chung CY; Li KKW
Int Ophthalmol; 2018 Dec; 38(6):2273-2282. PubMed ID: 28948453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
